Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HYGIEIA logo — Enhancing insulin therapy with personalized recommendations...

HYGIEIA

Enhancing insulin therapy with personalized recommendations for improved glycemic control through a smart glucose meter system.

Founded 2008 11-50 employees Series B Total: $35.29M Biotechnology, Health Care

General Information

Company Name HYGIEIA
Founded Year 2008
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when HYGIEIA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HYGIEIA

HYGIEIA is a biotechnology startup that focuses on enhancing insulin therapy through a smart glucose meter system. The company's main goal is to improve glycemic control through personalized recommendations. Its innovative insulin guidance system aims to simplify and enhance insulin therapy. This technology provides personalized insulin dosage recommendations based on changing blood glucose patterns, replacing the patient's current glucose meter. Founded in 2008, HYGIEIA has received a notable $5.00M Series B investment from Firstime VC on 02 May 2023. This investment reflects the confidence of the investor in the potential of HYGIEIA's technology to make a significant impact in the biotechnology and healthcare industries.

Taxonomy: Diabetes, Medical Technology, Insulin Therapy, Glycemic Control, Smart Glucose Meter, Personalized Medicine, Insulin Management, Digital Health, Endocrinology, Primary Care, Diabetes Management, Patient Monitoring, Health and Wellness, Medical Device

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
02 May 2023
Debt Financing •••••• - 06 Feb 2023
Series B •••••• 1
Investor
02 Dec 2021
Debt Financing •••••• - 25 Sep 2020
Debt Financing •••••• - 18 Nov 2019

View All 14 Funding Rounds

HYGIEIA Alternatives & Competitors

HYGIEIA vs
Portal Diabetes, Inc.
Portal Diabetes, Inc. United States

Freedom for people who use insulin.

Corporate Round
17 employees
Biotechnology, Health Care
HYGIEIA vs
Diatech Diabetes, Inc.
Diatech Diabetes, Inc. United States

Personalizing Insulin Delivery for People with Diabetes

Debt Financing
7 employees
Health Care, Medical Devices
HYGIEIA vs
Mini Med
Mini Med United States

Boldly transforming diabetes care together, for greater freedom & better health. 

4 employees
Health Care

FAQ About HYGIEIA

Enhancing insulin therapy with personalized recommendations for improved glycemic control through a smart glucose meter system.
HYGIEIA was founded in 2008.
HYGIEIA operates in the following industries: Biotechnology, Health Care.
HYGIEIA has approximately 11-50 employees.
HYGIEIA has completed 14 funding rounds, raising a total of $35.29M. The latest funding stage is Series B.
Top alternatives and competitors to HYGIEIA include Portal Diabetes, Inc., Diatech Diabetes, Inc., Mini Med, Dexcom UK, Zenomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HYGIEIA and Portal Diabetes, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HYGIEIA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy